Gene essentiality signatures for exploring cancer-relevant targets and mechanisms in large-scale drug sensitivity screens
Cancer drugs can produce phenotypic effects beyond their annotated targets, complicating mechanism-of-action (MoA) inference. We introduce gene-essentiality-derived signatures as a data-centric representation of drugs, learned by regressing cell-line drug sensitivity against genome-wide loss-of-function dependency profiles across hundreds of cancer cell lines. These interpretable vectors capture associations between drug response and gene dependencies. In supervised target prediction, the signatures outperformed chemical fingerprints and drug-perturbation transcriptomic signatures. Without target priors, top-ranked genes and their first-degree protein-protein interaction neighbors were enriched for known targets and pathway components, enabling de novo MoA exploration, including EGFR/HER2 signaling for lapatinib and DNA mismatch repair-linked compounds. We applied the framework to PRISM cancer cell-line screening data to predict cancer-relevant targets and MoAs for non-oncology drugs. Multiple predictions received orthogonal support from proteome-wide target deconvolution and structure-based docking, highlighting opportunities for oncology-focused drug repurposing. These interpretable, scalable embeddings support target and MoA hypothesis generation.
Authors
- Jie Bao (ORCID: https://orcid.org/0000-0002-1993-7309)
- Jehad Aldahdooh (ORCID: https://orcid.org/0000-0002-9947-4067)
- Yinyin Wang (ORCID: https://orcid.org/0000-0002-0323-5345)
- Ziaurrehman Tanoli (ORCID: https://orcid.org/0000-0003-2435-9862)
- Chuqi Lei (ORCID: https://orcid.org/0009-0007-5234-9924)
- Wenyu Wang (ORCID: https://orcid.org/0000-0003-2816-9740)
- Xuepei Zhang (ORCID: https://orcid.org/0000-0001-8304-8437)
- Johanna Eriksson (ORCID: https://orcid.org/0009-0006-2238-3227)
- Shan Huang
- Massimiliano Gaetani
- Min Li
- Jing Tang
- Shuyu Zheng
Institutions
- University of Helsinki (FI)
- Central South University (CN)
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- iScience
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1016/j.isci.2026.118287
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00